Yu Liu

9.8k citations
213 papers · 3.8k indexed · h-index 34
Topics
Genomics and Phylogenetic Studies (27 papers)Liver Disease Diagnosis and Treatment (15 papers)Hepatitis B Virus Studies (13 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Yu Liu

201 papers receiving 3.8k citations

Peers

Yu Liu
Comparison fields: 5 of 163
  • Molecular Biology 2.0k
  • Epidemiology 683
  • Oncology 501
  • Immunology 394
  • Genetics 344
Replace Yun Li with:
Yun Li China
Na Wang China
Martin Braddock United Kingdom
John Kim United States
Hua Yang China
Chiou‐Feng Lin Taiwan
Zahra Zakeri United States
Alan J. Tackett United States
Toru Yanagawa Japan
Jack Pollard United States
Yu Liu relative to Yun Li China Yun Li's profile →
Citations per field
00.5×1.5×
Yun Li · 1×
Citations per year

Countries citing papers authored by Yu Liu

Since Specialization
Citations

This map shows the geographic impact of Yu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Liu more than expected).

Fields of papers citing papers by Yu Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Liu. The network helps show where Yu Liu may publish in the future.

Co-authorship network of co-authors of Yu Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Liu. A scholar is included among the top collaborators of Yu Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Liu. Yu Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 4
3 0
4 4
5 2
6 6
7 4
8 1
9 2
10 55
11 0
12 16
13
Two TCF7L2 Variants Associated with Type 2 Diabetes in the Han Nationality Residents of China.
4
14 9
15 2
16 15
17 36
18
Study on the Molecular Mechanisms of dlk1 Stimulated Lung Cancer Cell Proliferation
1
19 32
20 152

About Yu Liu

Yu Liu is a scholar working on Virology, Epidemiology and Hematology, having authored 213 papers that have together received 3.8k indexed citations. Recurring topics across this work include Genomics and Phylogenetic Studies (27 papers), Liver Disease Diagnosis and Treatment (15 papers) and Hepatitis B Virus Studies (13 papers). The work is most often cited by research in Molecular Biology (2.0k citations), Virology (128 citations) and Cancer Research (335 citations). Yu Liu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Hung‐Ying Kao, Erin L. Reineke, Minh Lam, Mark R. Chance, Ao Li, Robert T. Jiménez, Zhiping Nie, Ariella M. Rosengard, Minghui Wang and Kristopher J. Stanya. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026